Single-cell RNA-Seq reveals the potential risk of anti-mesothelin CAR T Cell therapy toxicity to different organs in humans

“On-target off-tumor” toxicity is a major challenge to the use of chimeric antigen receptor (CAR)-engineered T cells in the treatment of solid malignancies, because of the expression of target antigens in normal tissues. Mesothelin overexpression is associated with poor prognosis of multiple solid t...

Descripción completa

Detalles Bibliográficos
Autores principales: Wen, Lu, Huang, Yu, Peng, Ling, Zhao, Kaiping, Sun, Yan, Lin, Zhicai, Chen, Yuanyuan, Li, Zhong, Qian, Qijun, Tong, Fan, Zhang, Ruiguang, Dong, Xiaorong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428152/
https://www.ncbi.nlm.nih.gov/pubmed/36059490
http://dx.doi.org/10.3389/fimmu.2022.807915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428152/
https://www.ncbi.nlm.nih.gov/pubmed/36059490
http://dx.doi.org/10.3389/fimmu.2022.807915

Ejemplares similares